𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Concomitant chemotherapy and radiotherapy for advanced squamous cell carcinoma of head and neck

✍ Scribed by Seung Shin Hahn; Jung-Ah Kim; William C. Constable


Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
118 KB
Volume
10
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pilot trial of concomitant chemotherapy
✍ Olavo Feher; Sandro J. Martins; Candice A. Lima; JoΓ£o V. Salvajoli; Andrew J. Si πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

## Abstract ## Purpose The combination of chemotherapy and irradiation is considered the standard of care for the treatment of advanced squamous cell carcinoma of head and neck (SCCHN). Paclitaxel has shown a single‐agent activity in SCCHN. Besides, this drug is a promising radiosensitizer for som

Adjuvant chemotherapy for advanced head
✍ Final report of the head; neck contracts program πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 1016 KB

To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Insitute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982,462 patients with resectable Sta

Combination chemotherapy for advanced sq
✍ Coker, Donald D. ;Elias, E. George ;Chretien, Paul B. ;Gray, William C. ;Coleman πŸ“‚ Article πŸ“… 1981 πŸ› Wiley (John Wiley & Sons) βš– 639 KB

## Abstract Fifty‐one patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__‐platinum (DDP), bleomycin (Bleo), Β± high dose methotrexate (MTX). Thirty‐th

Integration of chemotherapy in an MFD-ra
✍ Renzo Corvo; Drs. Marco Merlano; Dr. William B. Looney; Marco Benasso; Almalina πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 510 KB

patients with advanced squamous cell carcinoma of the head and neck received combined treatment, based on an alternating schedule of chemotherapy and multiple fractions per day (MFD)-radiotherapy. The chemotherapy regimen consisted of cisplatin, 20 mg/m2, followed by 5-fluorouracil (5-FU), 200 mg/m2